You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 3, February 12, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Treatment Adherence
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Adherence
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Influence of Patient Adherence on Anticoagulation Control With Warfarin

Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

Stephen E. Kimmel, MD, MSCE; Zhen Chen, PhD; Maureen Price, RN; Catherine S. Parker, MS; Joshua P. Metlay, MD, PhD; Jason D. Christie, MD, MSCE; Colleen M. Brensinger, MS; Craig W. Newcomb, MAR; Frederick F. Samaha, MD; Robert Gross, MD, MSCE

Arch Intern Med. 2007;167(3):229-235.

Background  Warfarin sodium is a highly efficacious drug, but proper levels of anticoagulation are difficult to maintain. Conflicting data exist on the influence of patient adherence on anticoagulation control.

Methods  We performed a prospective cohort study at 3 anticoagulation clinics to determine the effect of adherence on anticoagulation control. Patients treated with warfarin with a target international normalized ratio of 2.0 to 3.0 were monitored with electronic Medication Event Monitoring System (MEMS) medication bottle caps. Detailed information was collected on other factors that might alter warfarin response.

Results  Among 136 participants observed for a mean of 32 weeks, 92% had at least 1 missed or extra bottle opening; 36% missed more than 20% of their bottle openings; and 4% had more than 10% extra bottle openings. In multivariable analyses, there was a significant association between underadherence and underanticoagulation. For each 10% increase in missed pill bottle openings, there was a 14% increase in the odds of underanticoagulation (P<.001); participants with more than 20% missed bottle openings (1-2 missed days each week) had more than a 2-fold increase in the odds of underanticoagulation (adjusted odds ratio, 2.10; 95% confidence interval, 1.48-2.96). Participants who had extra pill bottle openings on more than 10% of days had a statistically significant increase in overanticoagulation (adjusted odds ratio, 1.73; 95% confidence interval, 1.09-2.74).

Conclusion  Patients have substantial difficulties maintaining adequate adherence with warfarin regimens, and this poor adherence has a significant effect on anticoagulation control.


Author Affiliations: Department of Medicine (Drs Kimmel, Metlay, Christie, Samaha, and Gross), Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics and Epidemiology (Drs Kimmel, Chen, Metlay, Christie, and Gross, Mss Price and Brensinger, and Mr Newcomb), University of Pennsylvania School of Medicine (Ms Parker), and Philadelphia Veterans Affairs Medical Center (Drs Metlay and Samaha), Philadelphia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control: Results From SPORTIF III and V
Harvey D. White, Michael Gruber, Jan Feyzi, Scott Kaatz, Hung-Fat Tse, Steen Husted, and Gregory W. Albers
Arch Intern Med. 2007;167(3):239-245.
ABSTRACT | FULL TEXT  

Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
Nicole L. Glazer, Sascha Dublin, Nicholas L. Smith, Benjamin French, Lisa A. Jackson, Jennifer B. Hrachovec, David S. Siscovick, Bruce M. Psaty, and Susan R. Heckbert
Arch Intern Med. 2007;167(3):246-252.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidemiology of Subtherapeutic Anticoagulation in the United States
Rose et al.
Circ Cardiovasc Qual Outcomes 2009;2:591-597.
ABSTRACT | FULL TEXT  

Intensifying Therapy for Hypertension Despite Suboptimal Adherence
Rose et al.
Hypertension 2009;54:524-529.
ABSTRACT | FULL TEXT  

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Witt et al.
Blood 2009;114:952-956.
ABSTRACT | FULL TEXT  

Effect of a Warfarin Adherence Aid on Anticoagulation Control in an Inner-City Anticoagulation Clinic Population
Nochowitz et al.
The Annals of Pharmacotherapy 2009;43:1165-1172.
ABSTRACT | FULL TEXT  

An update on cardioembolic stroke
Weir
Postgrad. Med. J. 2008;84:133-142.
ABSTRACT | FULL TEXT  

Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
Anderson et al.
Circulation 2007;116:2563-2570.
ABSTRACT | FULL TEXT  

Warfarin Therapy in Clinical Practice
JWatch Neurology 2007;2007:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.